Evidence map›Paper›PMID 24953651›Full record

ArticleCell reports2014

MOF phosphorylation by ATM regulates 53BP1-mediated double-strand break repair pathway choice.

Arun Gupta, Clayton R Hunt, Muralidhar L Hegde, Sharmistha Chakraborty, Sharmistha Chakraborty, Durga Udayakumar, Nobuo Horikoshi, Mayank Singh, Deepti B Ramnarain, Walter N Hittelman and 7 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Preventive nutrition and food science · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Functional Phosphoproteomics in Cancer Chemoresistance Using CRISPR-Mediated Base Editors.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

17 authors at 7 institutions in 1 country.

Arun GuptaDeparment of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63108, USA.
Clayton R HuntDeparment of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63108, USA; Department of Radiation Oncology, The Houston Methodist Research Institute, Houston, TX 77030, USA.
Muralidhar L Hegde
Sharmistha ChakrabortyDepartment of Radiation Oncology, The Houston Methodist Research Institute, Houston, TX 77030, USA; Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA.
Sharmistha ChakrabortyDeparment of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Durga UdayakumarDeparment of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Radiation Oncology, The Houston Methodist Research Institute, Houston, TX 77030, USA.
Nobuo HorikoshiDeparment of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63108, USA; Department of Radiation Oncology, The Houston Methodist Research Institute, Houston, TX 77030, USA.
Mayank SinghDeparment of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Deepti B RamnarainDeparment of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Walter N HittelmanDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Sarita NamjoshiDepartment of Biochemistry, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Aroumougame AsaithambyDeparment of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Tapas K HazraDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Thomas LudwigDepartment of Molecular and Cellular Biochemistry, The Ohio State University, Columbus, OH 43210, USA.
Raj K PanditaDepartment of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63108, USA; Department of Radiation Oncology, The Houston Methodist Research Institute, Houston, TX 77030, USA.
Jessica K TylerDepartment of Biochemistry, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Tej K PanditaDeparment of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63108, USA; Department of Radiation Oncology, The Houston Methodist Research Institute, Houston, TX 77030, USA. Electronic address: tpandita@houstonmethodist.org.
The University of Texas Southwestern Medical Center · USThe University of Texas MD Anderson Cancer Center · USWashington University in St. Louis · USMethodist Hospital · USSouthwestern Medical CenterThe Ohio State University · USThe University of Texas Medical Branch at Galveston · US

Funding

Chromatin's Role in Repair of Radiation-induced Damage.R01CA095641 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI TYLER, JESSICA K · 2002 to 2023
$5.2M
CHROMATIN MODIFYING FACTORS CONTROL RADIATION RESPONSE AND GENOMIC STABILITYR01CA129537 · NCI · WASHINGTON UNIVERSITY · PI PANDITA, TEJ K · 2008 to 2018
$3.3M
Tumor-cell-specific targets for combined hyperthermia and radiation effectsR01CA154320 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI PANDITA, TEJ K · 2010 to 2014
$1.6M
Role of Heterochromatin protein 1 Beta in Genome Maintenance and OncogenesisR01GM109768 · NIGMS · METHODIST HOSPITAL RESEARCH INSTITUTE · PI PANDITA, TEJ K · 2014 to 2017
$1.2M
NCI NIH HHS CA129537NCI NIH HHS CA154320NCI NIH HHS R01 CA095641NCI NIH HHS R01 CA129537NCI NIH HHS R01 CA154320NIGMS NIH HHS R01 GM109768
6 · The paper itself

Abstract

Cell-cycle phase is a critical determinant of the choice between DNA damage repair by nonhomologous end-joining (NHEJ) or homologous recombination (HR). Here, we report that double-strand breaks (DSBs) induce ATM-dependent MOF (a histone H4 acetyl-transferase) phosphorylation (p-T392-MOF) and that phosphorylated MOF colocalizes with γ-H2AX, ATM, and 53BP1 foci. Mutation of the phosphorylation site (MOF-T392A) impedes DNA repair in S and G2 phase but not G1 phase cells. Expression of MOF-T392A also blocks the reduction in DSB-associated 53BP1 seen in wild-type S/G2 phase cells, resulting in enhanced 53BP1 and reduced BRCA1 association. Decreased BRCA1 levels at DSB sites correlates with defective repairosome formation, reduced HR repair, and decreased cell survival following irradiation. These data support a model whereby ATM-mediated MOF-T392 phosphorylation modulates 53BP1 function to facilitate the subsequent recruitment of HR repair proteins, uncovering a regulatory role for MOF in DSB repair pathway choice during S/G2 phase.

Indexed as

Recombinational DNA RepairAnimalsAtaxia Telangiectasia Mutated ProteinsBRCA1 ProteinCell Line, TumorDNA Breaks, Double-StrandedG1 Phase Cell Cycle CheckpointsG2 Phase Cell Cycle CheckpointsHEK293 CellsHistone AcetyltransferasesHumansIntracellular Signaling Peptides and ProteinsMiceMutationPhosphorylationTumor Suppressor p53-Binding Protein 1Ataxia Telangiectasia Mutated ProteinsBRCA1 ProteinHistone AcetyltransferasesIntracellular Signaling Peptides and ProteinsKAT8 protein, humanTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1

Identifiers

PMID24953651
PMCPMC4300955
OpenAlexW1988353584

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.